BRIEF-FDA Approves Novartis Drug Promacta® For First-Line Saa And Grants Breakthrough Therapy Designation For Additional New Indication
1 分钟阅读
Nov 16 (Reuters) - Novartis AG:
* FDA APPROVES NOVARTIS DRUG PROMACTA® FOR FIRST-LINE SAA AND GRANTS BREAKTHROUGH THERAPY DESIGNATION FOR ADDITIONAL NEW INDICATION Source text for Eikon: Further company coverage: